Northwest Biotherapeutics Inc
NWBO· OTC
NWBONorthwest Biotherapeutics Inc
Filed Nov 14, 2011 · 10-Q · 45 days after period end · 0001144204-11-064125
| Metric | Q3 2011 | Q3 2010 |
|---|---|---|
| Revenue | $10.00K | $10.00K |
| Net Income | $482.00K | -$5.38M |
| EPS Diluted | $0.06 | -$0.08 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Northwest Biotherapeutics Inc · CIK 1072379 · Engraved from SEC EDGAR
ended Sep 30, 2011 · filed Nov 14, 2011 · 45 d after period end
